Keywords: Bone/Skeletal, Bone, Osteosarcoma, Neoadjuvant chemotherapy, IVIM, DCE-MRI, Habitat analysis
Motivation: To enhance early prediction of chemotherapy effectiveness in osteosarcoma, thereby improving personalized treatment strategies and patient outcomes.
Goal(s): This study investigates the potential of habitat analysis using Intravoxel Incoherent Motion (IVIM) and Dynamic Contrast-Enhanced MRI (DCE-MRI) to predict neoadjuvant chemotherapy (NACT) responses in osteosarcoma patients.
Approach: Analyzing 71 patients, we segmented functional images into eight habitats and identified key features linked to treatment outcomes.
Results: The HAB-IVIM-Bi model demonstrated strong predictive capabilities, achieving an AUC of 0.797.These findings suggest that integrating habitat analysis with IVIM and DCE-MRI can enhance personalized treatment planning and improve patient management in osteosarcoma.
Impact: This research highlights the utility of multiparametric MRI in predicting chemotherapy responses, paving the way for personalized treatment strategies and improved clinical outcomes for osteosarcoma patients. Future studies could further explore imaging biomarkers in diverse tumor subtypes.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords